Utility of Rifampin Blood Levels in the Treatment and Follow-up of Active Pulmonary Tuberculosis in Patients who Were Slow to Respond to Routine Directly Observed Therapy
- 1 November 2001
- Vol. 120 (5) , 1520-1524
- https://doi.org/10.1378/chest.120.5.1520
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Delayed Death From Pulmonary TuberculosisSouthern Medical Journal, 2000
- Stability of Rifampin in PlasmaTherapeutic Drug Monitoring, 1997
- Grand Rounds--Hammersmith Hospital: Persistent fever in pulmonary tuberculosisBMJ, 1996
- The Relationship Between Delayed or Incomplete Treatment and All-Cause Mortality in Patients With TuberculosisJAMA, 1996
- Why do our patients die of active tuberculosis in the era of effective therapy?Tubercle and Lung Disease, 1994
- Malabsorption of Antimycobacterial MedicationsNew England Journal of Medicine, 1993
- Initial Therapy for Tuberculosis in the Era of Multidrug Resistance: Recommendations of the Advisory Council for the Elimination of TuberculosisPublished by American Medical Association (AMA) ,1993
- Assessment of New Sterilizing Drugs for Treating Pulmonary Tuberculosis by Culture at 2 MonthsAmerican Review of Respiratory Disease, 1993
- Malabsorption of Antituberculosis Medications by a Patient with AIDSNew England Journal of Medicine, 1992
- Clinical Pharmacokinetics of RifampicinClinical Pharmacokinetics, 1978